Requests That the International Non-Proprietary Naming (INN) Policy Equally to all Biologics

RIN

—

Last modified

Jan 25, 2017

Comment window

—

American Pharmacists Association (APhA) filings

Activity

American Pharmacists Association (APhA) filed 1 comment on this docket between Mar 26, 2014 and Mar 26, 2014. 6 other organizations filed here.

What American Pharmacists Association (APhA) filed (1)

Mar 26, 2014· Comment from the American Pharmacists Association, et al.· FDA-2013-P-1153-0012

Please see the attached joint comments from the American Pharmacists Association (APhA), the National Association of Chain Drug Stores (NACDS) and the National Community Pharmacists Association (NCPA) regarding the citizen petitions filed by the Generic Pharmaceutical Association (FDA-2013-P-1153) and by the Novartis Group (FDA-2013-P-1398) relating to a naming convention for biosimilars.

View on regulations.gov →

Abstract

No abstract recorded.

View on regulations.gov →

Co-filers (6)

See everyone who commented →

American Pharmacists Association (APhA)THIS ORG
1 filing · confidence 97%
Generic Pharmaceutical Associationtrade assoc.
2 filings · confidence 85%
AbbVie Inc.unverified attribution
1 filing · confidence 70%
Global Healthy Living Foundationtrade assoc.
1 filing · confidence 85%
National Association of Boards of Pharmacytrade assoc.
1 filing · confidence 85%
National Council for Prescription Drug Programstrade assoc.
1 filing · confidence 85%
Pharmaceutical Care Management Associationtrade assoc.
1 filing · confidence 85%